Xebec Reveals Recent Major Order Comes From Chevron Joint Venture

Xebec Adsorption (TSX: XBC) this morning announced that it has received the first task orders under a major master services agreement announced in July. The order is for an initial 18 BGX-Biostream units, representing the largest purchase order received to date for the units by the company.

The order, and master services agreement, has been revealed to be with that of Brightmark RNG Holdings, which is a joint venture between Brightmark and Chevron Corp (NYSE: CVX). The units are to be used to produce renewable natural gas at ten different dairy farms across the US.

As has become a trend from Xebec, little actual detail was released this morning by the company. In fact, it appears this mornings announcement was primarily a means of announcing the master services agreement was related to Brightmark and Chevron, with the initial order of 18 units previously announced by the firm.

Selkirk Copper Mines — sponsored Sponsored · Selkirk Copper Mines

While financial details were not included this morning, in its initial announcement Xebec revealed that the Biostream units have an initial list price of US$1.5 million per each, meaning the transaction could represent significant revenues for the firm. A timeline for the estimated delivery of these units however was not provided.

Xebec Adsorption last traded at $2.63 on the TSX.


Information for this briefing was found via Sedar and Xebec Absorption Inc. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

A $2.2B Gold Project Is Outgrowing Its Plan | Michael Henrichsen – Gold X2 Mining

Pay for the Copper, Get the Gold Free | Rob McEwen – McEwen Inc

This Gold Discovery Was Already Huge. Now It’s Becoming a Monster. | Goliath Resources

Recommended

This Gold Discovery Just Keeps Getting Bigger | Roger Rosmus – Goliath Resources

Cardiol Expands MAVERIC Trial to Up to 150 Patients After Reaching Enrollment Target Early

Related News

Xebec Adsorption Sees BMO Initiate Coverage With $5.60 Price Target

Xebex Adsorption (TSX: XBC) is up almost 9% to $4.74 in early morning trade after...

Friday, May 21, 2021, 04:19:00 PM

“He’s Mildly Sensitive”: Biden Says About Chevron CEO For Calling Out The White House On “Vilifying” Oil Industry

Speaking at a briefing on Tuesday, President Joe Biden commented on the letter from Chevron...

Thursday, June 23, 2022, 03:40:00 PM

Xebec Adsorption Hits $32.7 Million In Revenue, $7.5 Million Net Loss In Q2 2021

Xebec Adsorption Inc. (TSX: XBC) announced today its financial results for Q2 2021, which recorded...

Thursday, August 12, 2021, 09:37:00 AM

Canaccord Lifts Xebec Adsorption’s Price Target To $5.00

On November 11th, Xebec Adsorption (TSX: XBC) announced its third quarter financial results. The company...

Sunday, November 21, 2021, 01:22:00 PM

Canaccord Genuity Resumes Coverage On Xebec Adsorption With C$6 Price Target

This morning Canaccord Genuity resumed their coverage on Xebec Adsorption (TSXV: XBC) with a Speculative...

Thursday, September 17, 2020, 01:15:32 PM